Clinical Trials
Braintumor Website

There are 9 trials:
Facility: Cedars Sinai Medical Center
NCT Trial Name# of Centers

NCT02179086

  Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
144

NCT02667587

  An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
120

NCT02546102

  Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
64

NCT01434602

  Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
18

NCT02078648

  Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
16

NCT00001404

  Phenotype and Etiology of Pallister-Hall Syndrome
4

NCT01235793

  The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma
1

NCT01792505

  Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma
1

NCT02360917

  Emerging From the Hazeā„¢- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites